Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion

Autor: Paul J. Michiels, Tinka Tuinstra, Joram M. Posma, Sybren S. Wijmenga, Frederic C. Girard, Lutgarde M. C. Buydens, Lionel Blanchet, Theo M. Luider, Agnieszka Smolinska, Amos Attali, Kirsten A.M. Ampt, Marek Doskocz
Přispěvatelé: Farmacologie en Toxicologie, RS: NUTRIM - R4 - Gene-environment interaction, Erasmus MC other, Neurology
Rok vydání: 2012
Předmět:
Zdroj: Analytical and Bioanalytical Chemistry, 403, 4, pp. 947-959
Analytical and Bioanalytical Chemistry, 403, 947-959
Analytical and Bioanalytical Chemistry, 403(4), 947-59. Springer
Analytical and Bioanalytical Chemistry, 403(4), 947-959. Springer-Verlag
Analytical and Bioanalytical Chemistry
ISSN: 1618-2642
Popis: Because cerebrospinal fluid (CSF) is the biofluid which interacts most closely with the central nervous system, it holds promise as a reporter of neurological disease, for example multiple sclerosis (MScl). To characterize the metabolomics profile of neuroinflammatory aspects of this disease we studied an animal model of MScl—experimental autoimmune/allergic encephalomyelitis (EAE). Because CSF also exchanges metabolites with blood via the blood–brain barrier, malfunctions occurring in the CNS may be reflected in the biochemical composition of blood plasma. The combination of blood plasma and CSF provides more complete information about the disease. Both biofluids can be studied by use of NMR spectroscopy. It is then necessary to perform combined analysis of the two different datasets. Mid-level data fusion was therefore applied to blood plasma and CSF datasets. First, relevant information was extracted from each biofluid dataset by use of linear support vector machine recursive feature elimination. The selected variables from each dataset were concatenated for joint analysis by partial least squares discriminant analysis (PLS-DA). The combined metabolomics information from plasma and CSF enables more efficient and reliable discrimination of the onset of EAE. Second, we introduced hierarchical models fusion, in which previously developed PLS-DA models are hierarchically combined. We show that this approach enables neuroinflamed rats (even on the day of onset) to be distinguished from either healthy or peripherally inflamed rats. Moreover, progression of EAE can be investigated because the model separates the onset and peak of the disease. Figure Graphical representation of Hierarchical Models Fusion applied to concatenated plasma and CSF datasets. Electronic supplementary material The online version of this article (doi:10.1007/s00216-012-5871-4) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE